featured
Isatuximab as Monotherapy and Combined With Dexamethasone for Relapsed/Refractory Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Isatuximab as Monotherapy and Combined With Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
Blood 2020 Oct 20;[EPub Ahead of Print], MA Dimopoulos, S Bringhen, PM Anttila, M Capra, M Cavo, CE Cole, C Gasparetto, VTM Hungria, MW Jenner, VI Vorobyev, EP Yanez Ruiz, JY Yin, R Saleem, M Hellet, S Macé, B Paiva, R VijFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.